164 related articles for article (PubMed ID: 8014326)
1. Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo.
Pollack MH; Otto MW; Sachs GS; Leon A; Shear MK; Deltito JA; Keller MB; Rosenbaum JF
J Affect Disord; 1994 Apr; 30(4):273-81. PubMed ID: 8014326
[TBL] [Abstract][Full Text] [Related]
2. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo.
Keller MB; Lavori PW; Goldenberg IM; Baker LA; Pollack MH; Sachs GS; Rosenbaum JF; Deltito JA; Leon A; Shear K
J Affect Disord; 1993 May; 28(1):27-38. PubMed ID: 8326078
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder.
Schweizer E; Patterson W; Rickels K; Rosenthal M
Am J Psychiatry; 1993 Aug; 150(8):1210-5. PubMed ID: 8328566
[TBL] [Abstract][Full Text] [Related]
4. Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response.
Rosenberg R; Bech P; Mellergård M; Ottosson JO
Acta Psychiatr Scand Suppl; 1991; 365():46-52. PubMed ID: 1862734
[TBL] [Abstract][Full Text] [Related]
5. Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
Deltito JA; Argyle N; Klerman GL
J Clin Psychiatry; 1991 Mar; 52(3):121-7. PubMed ID: 2005075
[TBL] [Abstract][Full Text] [Related]
6. Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
Schweizer E; Rickels K; Weiss S; Zavodnick S
Arch Gen Psychiatry; 1993 Jan; 50(1):51-60. PubMed ID: 8422222
[TBL] [Abstract][Full Text] [Related]
7. Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper.
Rickels K; Schweizer E; Weiss S; Zavodnick S
Arch Gen Psychiatry; 1993 Jan; 50(1):61-8. PubMed ID: 8422223
[TBL] [Abstract][Full Text] [Related]
8. Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression.
Rickels K; Chung HR; Csanalosi IB; Hurowitz AM; London J; Wiseman K; Kaplan M; Amsterdam JD
Arch Gen Psychiatry; 1987 Oct; 44(10):862-6. PubMed ID: 3310952
[TBL] [Abstract][Full Text] [Related]
9. Treatment of panic disorder in older adults: a pilot study comparison of alprazolam, imipramine, and placebo.
Sheikh JI; Swales PJ
Int J Psychiatry Med; 1999; 29(1):107-17. PubMed ID: 10376237
[TBL] [Abstract][Full Text] [Related]
10. The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder: a double-blind placebo-controlled study.
Sheehan DV; Raj AB; Harnett-Sheehan K; Soto S; Knapp E
Acta Psychiatr Scand; 1993 Jul; 88(1):1-11. PubMed ID: 8372689
[TBL] [Abstract][Full Text] [Related]
11. Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.
Maier W; Rosenberg R; Argyle N; Buller R; Roth M; Brandon S; Benkert O
Eur Arch Psychiatry Clin Neurosci; 1991; 241(1):22-30. PubMed ID: 1832302
[TBL] [Abstract][Full Text] [Related]
12. The structure of phobias in panic disorder.
Argyle N; Solyom C; Solyom L
Br J Psychiatry; 1991 Sep; 159():378-82. PubMed ID: 1958949
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
Taylor CB; Hayward C; King R; Ehlers A; Margraf J; Maddock R; Clark D; Roth WT; Agras WS
J Clin Psychopharmacol; 1990 Apr; 10(2):112-8. PubMed ID: 2187912
[TBL] [Abstract][Full Text] [Related]
14. Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Cross-National Collaborative Panic Study, Second Phase Investigators.
Br J Psychiatry; 1992 Feb; 160():191-202; discussion 202-5. PubMed ID: 1540759
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies of pharmacotherapy for school refusal.
Bernstein GA; Garfinkel BD; Borchardt CM
J Am Acad Child Adolesc Psychiatry; 1990 Sep; 29(5):773-81. PubMed ID: 2228932
[TBL] [Abstract][Full Text] [Related]
16. Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment.
Rosenberg R; Bech P; Mellergård M; Ottosson JO
Acta Psychiatr Scand Suppl; 1991; 365():39-45. PubMed ID: 1862733
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of the effect of alprazolam, imipramine and placebo in the treatment of panic disorders in Cali, Colombia].
León CA; De Arango MV; Arevalo W; Calvo A; Montoya A; León A
Acta Psiquiatr Psicol Am Lat; 1990; 36(1-2):59-72. PubMed ID: 2073024
[TBL] [Abstract][Full Text] [Related]
18. A double-blind clinical trial of alprazolam, imipramine, or placebo in the depressed elderly.
Weissman MM; Prusoff B; Sholomskas AJ; Greenwald S
J Clin Psychopharmacol; 1992 Jun; 12(3):175-82. PubMed ID: 1629383
[TBL] [Abstract][Full Text] [Related]
19. Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?
Maier W; Roth SM; Argyle N; Buller R; Lavori P; Brandon S; Benkert O
Eur Arch Psychiatry Clin Neurosci; 1991; 241(3):151-8. PubMed ID: 1790160
[TBL] [Abstract][Full Text] [Related]
20. Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo.
Cassano GB; Toni C; Petracca A; Deltito J; Benkert O; Curtis G; Hippius H; Maier W; Shera D; Klerman G
Eur Neuropsychopharmacol; 1994 Mar; 4(1):47-53. PubMed ID: 8204996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
